OtherPHARMACOLOGY VIGNETTE
Bevacizumab (Avastin)
S.K. Mukherji
American Journal of Neuroradiology December 2009, DOI: https://doi.org/10.3174/ajnr.A1987


This is a PDF-only article. The first page of the PDF of this article appears above.
Advertisement
S.K. Mukherji
Bevacizumab (Avastin)
American Journal of Neuroradiology Dec 2009, DOI: 10.3174/ajnr.A1987
0 Responses
Jump to section
Related Articles
- No related articles found.
Cited By...
- Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials
- Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH
- Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy
- An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain
- Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient
- Metabolic Response of Glioblastoma to Superselective Intra-Arterial Cerebral Infusion of Bevacizumab: A Proton MR Spectroscopic Imaging Study
- Characteristics of Oral Mucosal Events Related to Bevacizumab Treatment
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement